Covid may have faded from the headlines, but for vulnerable members of certain high-risk groups, such as adults over 60 and people with weakened immune systems, the danger remains.
The New York Times reports that even now, after the World Health Organization and the US government officially ended the three-year-old coronavirus public health emergency, more than 1,000 people in the United States are still dying each week from the disease.
Prevention and treatment remain crucial for older adults and those with weakened immune systems, Covid is still present in the environment – even during the warm summer months – and can cause sickness and even death.
Enovid, an anti-viral spray developed in Canada by an Israeli researcher in Israel, has been proven effective in preventing common winter viruses – and COVID-19 – from entering the body through the nasal cavity.
prijevod
Covid je možda nestao s
naslovnica, ali za ranjive članove određenih visokorizičnih skupina, poput
odraslih starijih od 60 godina i ljudi s oslabljenim imunološkim sustavom,
opasnost i dalje postoji.
New York Times izvještava da čak i sada,
nakon što su Svjetska zdravstvena organizacija i američka vlada službeno
okončale trogodišnju opasnost zbog koronavirusa, više od 1000
ljudi u Sjedinjenim Državama još uvijek umire svaki tjedan od te bolesti.
Prevencija i liječenje i dalje su ključni za starije odrasle
osobe i one s oslabljenim imunološkim sustavom jer je Covid još uvijek prisutan u okolišu – čak i tijekom toplih
ljetnih mjeseci – i može uzrokovati bolest, pa čak i smrt.
Enovid, antivirusni sprej koji je u Kanadi razvio izraelski
istraživač pokazao se učinkovitim u sprečavanju uobičajenih zimskih
virusa – i COVID-19 – da uđu u tijelo kroz nosnu šupljinu.